申请人:Synta Pharmaceuticals Corp.
公开号:US20130309272A1
公开(公告)日:2013-11-21
The invention relates to compounds of structural formula (I) and structural formula (VI):
or a pharmaceutically acceptable salt, solvate, clathrate, or prodrug thereof, wherein R, R
1
, R
2
, Z, L, and n are defined herein. These compounds are useful as immunosuppressive agents and for treating and preventing inflammatory conditions, allergic disorders, and immune disorders.
本发明涉及结构式(I)和结构式(VI)的化合物:或其药学上可接受的盐、溶剂化物、包合物或前药,其中R、R1、R2、Z、L和n的定义如下。这些化合物可用作免疫抑制剂,用于治疗和预防炎症状况、过敏性疾病和免疫性疾病。